Literature DB >> 3822659

American Academy of Pediatrics Committee on Infectious Diseases: Ribavirin therapy of respiratory syncytial virus.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3822659

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  11 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Lower airway obstruction in the PICU.

Authors:  S A Kecskes
Journal:  Indian J Pediatr       Date:  1990 Mar-Apr       Impact factor: 1.967

3.  Reliability of two new test kits for rapid diagnosis of respiratory syncytial virus infection.

Authors:  P H Rothbarth; M C Hermus; P Schrijnemakers
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

4.  Mechanical ventilation and respiratory syncytial virus infection.

Authors:  H A van Steensel-Moll; W J Tissing; M Offringa; J A Hazelzet
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

5.  Lower airway disease caused by respiratory syncytial virus.

Authors:  R Aggarwal
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

Review 6.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  Relationship between clinical severity of respiratory syncytial virus infection and subtype.

Authors:  M C Kneyber; A H Brandenburg; P H Rothbarth; R de Groot; A Ott; H A van Steensel-Moll
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

Review 8.  Respiratory syncytial virus infection in children with congenital heart disease: a review.

Authors:  D E Fixler
Journal:  Pediatr Cardiol       Date:  1996 May-Jun       Impact factor: 1.655

Review 9.  Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery.

Authors:  M G Ottolini; V G Hemming
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 10.  Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.

Authors:  Tony Velkov; Nusaibah Abdul Rahim; Qi Tony Zhou; Hak-Kim Chan; Jian Li
Journal:  Adv Drug Deliv Rev       Date:  2014-11-12       Impact factor: 15.470
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.